Trial intelligence / Profile preview

Chloral Hydrate for Sedation in Pediatric ABR

NCT00949780Phase 2Completed

Sponsor
Pontifícia Universidade Católica de São Paulo
Start
Oct 2007
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of chloral hydrate in hearing loss, sponsored by Pontifícia Universidade Católica de São Paulo. Primary endpoint: Number of patients who achieved sleep at 1 hour. Started Oct 2007; status: completed.

02

Drugs

chloral hydrate
03

Conditions

hearing loss

Beyond the preview

Go deeper on NCT00949780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00949780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call